Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW; CREDENCE Trial Investigators.

N Engl J Med. 2019 Apr 14. doi: 10.1056/NEJMoa1811744. [Epub ahead of print]

PMID:
30990260
2.

Renal safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus.

Desai M, Yavin Y, Balis D, Sun D, Xie J, Canovatchel W, Rosenthal N.

Diabetes Obes Metab. 2017 Jun;19(6):897-900. doi: 10.1111/dom.12876. Epub 2017 Mar 16.

3.

Long-Term Safety of Dapagliflozin in Older Patients with Type 2 Diabetes Mellitus: A Pooled Analysis of Phase IIb/III Studies.

Fioretto P, Mansfield TA, Ptaszynska A, Yavin Y, Johnsson E, Parikh S.

Drugs Aging. 2016 Jul;33(7):511-22. doi: 10.1007/s40266-016-0382-1.

4.

Osmotic diuresis with SGLT2 inhibition: analysis of events related to volume reduction in dapagliflozin clinical trials.

Johnsson K, Johnsson E, Mansfield TA, Yavin Y, Ptaszynska A, Parikh SJ.

Postgrad Med. 2016 May;128(4):346-55. doi: 10.1080/00325481.2016.1153941. Epub 2016 Mar 2.

PMID:
26878357
5.

Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis.

Yavin Y, Mansfield TA, Ptaszynska A, Johnsson K, Parikh S, Johnsson E.

Diabetes Ther. 2016 Mar;7(1):125-37. doi: 10.1007/s13300-015-0150-y. Epub 2016 Jan 12.

6.

Will a once-weekly anticoagulant for the treatment and secondary prevention of thromboembolism improve adherence?

Cohen AT, Maillardet L, Yavin Y.

Thromb Haemost. 2009 Mar;101(3):422-7.

PMID:
19277401
7.

Venous thromboembolism prophylaxis for the medical patient: where do we stand?

Yavin Y, Cohen AT.

Semin Respir Crit Care Med. 2008 Feb;29(1):75-82. doi: 10.1055/s-2008-1047565. Review.

PMID:
18302089
8.

Tracking control of a rolling disk.

Frangos C, Yavin Y.

IEEE Trans Syst Man Cybern B Cybern. 2000;30(2):364-72. doi: 10.1109/3477.836385.

PMID:
18244763
9.

Pharmacological prevention of venous thromboembolism in medical patients at risk.

Wolozinsky M, Yavin YY, Cohen AT.

Am J Cardiovasc Drugs. 2005;5(6):409-15. Review.

PMID:
16259529
10.

New antithrombotics in the prevention of thromboembolic disease.

Yavin YY, Wolozinsky M, Cohen AT.

Eur J Intern Med. 2005 Aug;16(4):257-66.

PMID:
16084352

Supplemental Content

Support Center